These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11592123)

  • 61. Effect of externally added carnitine on the synthesis of acetylcholine in rat cerebral cortex cells.
    Wawrzeńczyk A; Nałecz KA; Nałecz MJ
    Neurochem Int; 1995 Jun; 26(6):635-41. PubMed ID: 7670366
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of mitochondrial cofactors and antioxidants supplementation on cognition in the aged canine.
    Snigdha S; de Rivera C; Milgram NW; Cotman CW
    Neurobiol Aging; 2016 Jan; 37():171-178. PubMed ID: 26481404
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders.
    Maldonado C; Vázquez M; Fagiolino P
    Curr Pharm Des; 2020; 26(12):1277-1285. PubMed ID: 32048954
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of long-term acetyl-L-carnitine on stress-induced analgesia in the aging rat.
    Ghirardi O; Caprioli A; Ramacci MT; Angelucci L
    Exp Gerontol; 1994; 29(5):569-74. PubMed ID: 7828664
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mitochondrial DNA transcription and translation in aged rat. Effect of acetyl-L-carnitine.
    Gadaleta MN; Petruzzella V; Daddabbo L; Olivieri C; Fracasso F; Loguercio Polosa P; Cantatore P
    Ann N Y Acad Sci; 1994 Jun; 717():150-60. PubMed ID: 7518198
    [No Abstract]   [Full Text] [Related]  

  • 66. Acetylcarnitine and cholinergic receptors.
    Reed KW; Murray WJ; Roche EB
    J Pharm Sci; 1980 Sep; 69(9):1065-8. PubMed ID: 7411410
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acetylcholinesterase activity of synaptic plasma membranes during ageing: effect of L-acetylcarnitine.
    Gorini A; Ghigini B; Villa RF
    Dementia; 1996; 7(3):147-54. PubMed ID: 8740629
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of L-carnitine on T-maze learning ability in aged rats.
    Lohninger S; Strasser A; Bubna-Littitz H
    Arch Gerontol Geriatr; 2001 Jun; 32(3):245-53. PubMed ID: 11395170
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
    Rai G; Wright G; Scott L; Beston B; Rest J; Exton-Smith AN
    Curr Med Res Opin; 1990; 11(10):638-47. PubMed ID: 2178869
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.
    Sano M; Bell K; Cote L; Dooneief G; Lawton A; Legler L; Marder K; Naini A; Stern Y; Mayeux R
    Arch Neurol; 1992 Nov; 49(11):1137-41. PubMed ID: 1444880
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M
    Neurology; 1991 Nov; 41(11):1726-32. PubMed ID: 1944900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
    Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy.
    Ruggenenti P; Cattaneo D; Loriga G; Ledda F; Motterlini N; Gherardi G; Orisio S; Remuzzi G
    Hypertension; 2009 Sep; 54(3):567-74. PubMed ID: 19620516
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
    Rebouche CJ
    Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
    Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
    Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
    Bonavita E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The neurobiology of acetyl-L-carnitine.
    Traina G
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1314-29. PubMed ID: 27100509
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acetyl-L-carnitine improves aged brain function.
    Kobayashi S; Iwamoto M; Kon K; Waki H; Ando S; Tanaka Y
    Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S99-106. PubMed ID: 20590847
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic acetyl-L-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice.
    Smeland OB; Meisingset TW; Borges K; Sonnewald U
    Neurochem Int; 2012 Jul; 61(1):100-7. PubMed ID: 22549035
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials.
    Pooyandjoo M; Nouhi M; Shab-Bidar S; Djafarian K; Olyaeemanesh A
    Obes Rev; 2016 Oct; 17(10):970-6. PubMed ID: 27335245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.